BDBM50077055 3-{1-[(S)-3-Benzothiazol-2-yl-2-(3,3-dimethyl-1,2,3,4-tetrahydro-quinoline-8-sulfonylamino)-propionyl]-piperidin-4-yl}-propionic acid::CHEMBL28439
SMILES: CC1(C)CNc2c(C1)cccc2S(=O)(=O)N[C@@H](Cc1nc2ccccc2s1)C(=O)N1CCC(CCC(O)=O)CC1
InChI Key: InChIKey=JGVWSUQFPXEXQG-QFIPXVFZSA-N
Data: 1 KI
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prothrombin (Homo sapiens (Human)) | BDBM50077055 (3-{1-[(S)-3-Benzothiazol-2-yl-2-(3,3-dimethyl-1,2,...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | 7.83E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Horsham Research Center Curated by ChEMBL | Assay Description Inhibition of human thrombin (in vitro) | Bioorg Med Chem Lett 9: 1317-22 (1999) BindingDB Entry DOI: 10.7270/Q2ZW1K31 | |||||||||||
More data for this Ligand-Target Pair |